Guild Esports has gone public on the London Stock Exchange.
The e-sports company, which is co-owned by David Beckham, listed today after earlier this week offering 250m ordinary shares for 8p.
Beckham holds a 4.78% stake in Guild Esports.
It is the first e-sports company to go public on the stock exchange and has a valuation of £41.2m. The industry has experienced significant growth in recent years.
Jamie Peel, director at corporate finance at Zeus Capital, said: “The gaming industry has exploded in popularity, with esports quickly becoming a mainstream form of entertainment. This is only expected to accelerate in the coming years, and with a hugely experienced and high-quality management team, the firm has already generated significant investor appetite.”
Time to invest in e-sports?
Hiran Adhia, who is a client manager at global branding and design agency Landor, believes the e-sports sector will continue to grow in the coming years.
“[This float] has certainly got the international community talking and major players and investors have no choice but to now pay close attention,” said Adhia.
“[After] having perceptually trailed behind traditional sports franchises for the last 20 years, out of the limelight, e-sports has built a mammoth international fanbase,” they added.
According to games market insight company, Newzoo, the e-sports sector is set to grow by 42% to $1.56bn
Advanced Oncotherapy (AIM:AVO), developer of proton therapy systems for cancer treatment, recently announced several areas of progress which will help realise its goal of ‘democratising proton therapy’.
First, it stated that it had seen ‘strong advancement’ in its proton treatment technology, over the last six months. Its LIGHT system, upon completion, is set to be the first of its kind to be capable of accelerating protons at 230 MeV. The company states that it is on track to deliver its breakthrough technology to consumers in 2021, providing access to a type of treatment previously reserved for a select few.
In service of this end, the company’s second update was also promising. It announced that it had successfully delivered all of the high-precision accelerating structures for the LIGHT system to its Daresbury assembly site; that it had manufactured the hardware necessary for the patient positioning system; and had delivered all of the technical files for the certification process.
Further, it announced that at its Daresbury site, it had been developing the infrastructure necessary to support the assembly of future machines. In short, it is another step closer to bringing its technology to the public.
Then, to help with the costs of research and production, Advanced Oncotherapy celebrated several new sources of funding. These included a successful equity fundraise of £14.9 million pre-expenses; the option of accessing £42 million courtesy of VDL and Nerano Pharma; and a drawdown of $10 million from an ‘interest-bearing secured convertible facility’ with Nerano Pharma.
Finally, to assist in rolling out its treatment to patients, the company announced that it had signed ‘multiple’ commercial partnership agreements with stakeholders, including The London Clinic, The Mediterranean Hospital of Limassol and University Hospital Birmingham NHS Foundation Trust
Commenting on these areas of progress made over the last six months, Advanced Oncotherapy CEO, Nicolas Serandour, said:
“We are delighted with the progress achieved over the past sixmonths despite the impact that COVID-19 has had on our business. As previously announced, we have added more focus on and made excellent progress with the documentation and software development. During the half year under review, we also signed a number of significant collaborations with partners for further LIGHT systems to be constructed at world leading hospitals, and we look forward to updating the market in due course on the progress of these agreements.”
“We are pleased to have recently resumed activities at the Daresbury site, and are expecting to be in line with our operational plan for completion of the first LIGHT system in 2021. We will be holding a virtual Investor Day in October when we will update the market on our patient-centric business model, the broader strategy and operational deliverables for the next year, including our LIGHT system being fully conditioned and generating a full-energy beam that is necessary to treat patients with our clinical partner, the University Hospital Birmingham NHS Foundation Trust.”
Findings published by the Centre for Research on Multinational Corporations (SOMO) reveal that German coronavirus test manufacturer, and biotech giant, Qiagen (NYSE:QGEN) has dodged millions of euros in tax since 2010, owing to tax avoidance constructions in Ireland, Luxembourg, Malta and the US.
SOMO said in its report that Qiagen acts as a leading producer of Covid test kits, and currently benefits from mass orders made by ‘governments around the world’ – including being one of the major suppliers to the US.
Speaking on the findings, SOMO tax researcher, Jasper van Teeffelen, said: “The global healthcare sector is under enormous financial pressure due to the coronavirus crisis. It is distressing to see that precisely a company like Qiagen is avoiding tax on a large scale and depriving governments of much-needed income.”
How have Qiagen gotten away with it?
The company itself has an operational HQ in Germany, but is officially headquartered in Venlo, the Netherlands. Having boasted second quarter profits of €77 billion – double the level of the same period the previous year – SOMO revealed that the company had not paid proportionate tax on these gains. Instead, SOMO described Qiagen’s tax structure as a ‘network of letterbox companies’ in European tax havens (listed above), which it uses to avoid tax via internal loan-giving between subsidiaries.
In essence, it downplays the true nature of its taxable profits – which might differ from the profit figure it uses as a public performance indicator – by transferring its earnings to lower-tax jurisdictions such as Luxembourg. These transfers occur via loans, with the main company paying letterbox or subsidiary companies disproportionate interest payments. Much like ‘facilitation payments’ replacing bribery in the past, bogus ‘interest rates’ are just a form of euphemism to mask an unsavoury, but financially prudent, transaction.
Qiagen loan structure, SOMO graphic
According to SOMO’s estimates, Qiagen has avoided paying €93 million in tax, along with an accumulated tax deduction of €49 million. SOMO adds that this is a conservative estimate, given that not all of the potential avoidance structures have been accounted for. This report focused on intercompany loans but also mentions tax avoidance on interest income from Qiagen loans to the US.
Reacting to what the research group have uncovered, SOMO tax researcher, Vincent Kiezebrink, commented:
“It is shocking to see how hard this biotech giant is trying to avoid tax. We call on Qiagen and the EU to put an end to such tax avoidance schemes.”
Taking from the public and not giving back their fair share
Alongside not paying an equitable tax on their profits, Qiagen has received large sums of public funds from both the US and Netherlands governments, among others. For instance, it received €511,000 from the US Department of Health, to help accelerate the development of a new Covid test. The subsequent test is now being produced and procured on a massive scale, again using public money, by the Netherlands, US and other countries around the world
SOMO’s view is that government’s must intervene, with this just the latest in a catalogue of brazen tax avoidance schemes by large companies, who are happy to benefit from the countries they operate in, without feeling any duty of reciprocity towards the people who have facilitated their success.
It says that organisations such as the EU and the Netherlands government must now implement rules that are more exacting with the allocation of public funds, and tighter on tax avoidance infrastructure, such as subsidiaries being used to offshore profits made in a company’s places of operation.
Wemos, a Dutch non-profit, global health lobbyist group, published its own study on public funding of medicines in 2019, underlines the recommendations of the SOMOS report.
Ella Weggen, global health advocate for Wemos, said: “Transparency about public investments is desperately needed. Conditions must be attached to this public funding in terms of affordability and accessibility, so that people actually benefit from medicines and medical devices developed with their taxpayers’ money.”
The UK government has released a statement confirming a £200 million investment in the Port Infrastructure Fund, as part of its drive to “ramp up preparations for the end of the transition period” and build new facilities along the coast designed to “handle new customs requirements under the new Border Operating Model” proposed back in July.
Primarily targeting ports which already have “the space to build new border infrastructure on their current sites”, the funding will be put towards a “range of vital port infrastructure – from warehouses and control posts to traffic management systems” as well as inland customs facilities in areas which are not suitable for additional port infrastructure.
In a statement on its website, the UK government said that new port facilities will be necessary regardless of the outcome of ongoing Brexit negotiations with the European Union:
“New infrastructure at ports will be needed whether or not the UK secures a negotiated agreement with the EU as we are leaving the Customs Union and Single Market and new procedures will be coming into place”.
The post-Brexit fund will see construction commence “for the end of the year” and “give industry confidence that all required infrastructure will be delivered on time”.
Secretary of State for Transport, Grant Shapps, welcomed the government’s Friday announcement:
“Our ports are a point of pride for the UK, contributing to our success as a global trading nation and helping bring vital goods into the country each and every day. This investment will not only ensure our borders are fully operational at the end of the transition period, but will also support the UK’s fantastic businesses as they trade across Europe”.
Tim Morris of the UK Major Ports Group, the trade association for the UK’s largest port operators, added:
“Today’s announcement is a welcome step in ensuring that [port] capacity can be maximised and UK supply chains can be more resilient. Time is short and it is vital that UK businesses prepare for new border arrangements. We will work urgently with the Government on the all-important detail and related regulations”.
Last month it was a revealed that the government’s reasonable worst-case scenario (RWCS) prediction involved 40-70% of trucks travelling to the EU “not being ready for new border controls” and warned that a “lack of capacity to hold unready vehicles in France, or turn away freight prior to boarding in the UK, could reduce the flow rate to as low as 60-80% of normal levels, which could lead to queues of up to 7,000 vehicles in Kent and maximum delays of up to two days”.
With the outcome of Brexit negotiations still unclear, the fund is a welcome relief in ensuring that cross-border trade – along the coast, at least – is handled as efficiently as possible, whatever the outcome of the talks.
Copenhagen Infrastructure Partners (CPI) have secured €4 billion from investors in commitments for its new renewable energy fund, Copenhagen Infrastructure IV (CIP IV).
The Danish investment firm – which specialises in renewable infrastructure projects, particularly wind power – has attracted investors from across the Nordic countries, as well as the UK and Australia.
Expected to be one of the largest ever funds of its kind, CIP IV was launched five months ago with a target between €5 billion and €5.7 billion, and will focus on greenfield investment in energy infrastructure around the world.
The project will see CPI adopting investments across a range of climate-conscious technologies, such as: contracted offshore wind, onshore wind, solar PV, transmission, storage, and waste-to-energy in low-risk Organisation for Economic Co-operation and Development (OECD) countries in the Northern Hemisphere, as well as developed countries in Asia and Australia.
“Tailored to institutional investors with a long-term investment horizon”, CIP has described the scheme as a “promising” addition to a market which has “proven resilient and functioned well over the last six months, despite Covid-19 and market turmoil”.
Among the contributors to the fund are two Danish pension funds, PensionDanmark and AP Pension, as well as an assortment of other pension and life insurance companies based in the region.
“Several new prominent institutional investors from across the Nordics, Continental Europe, the UK, Israel, Taiwan, Japan, and Australia” have also submitted plans to commit to the project, CIP said in a statement on its website.
Jakob Baruël Poulsen, Managing Partner at CIP, commented on the firm’s announcement, saying:
“We are very pleased with our investors’ continued confidence in CIP’s approach to energy infrastructure investments and look forward to continuing to create value for our investors, project partners, and communities through the fund’s investments.
“As a renewables market leader and pioneer, we are very happy to observe continued strong appetite for renewables. The investments of the CIP flagship funds have long-term contracted cash flows and robust investment structures, including low energy price risk exposure and cautious use of financial leverage, and have proven resilient and non-cyclical.
“The investment outlook for CI IV is very promising and we expect the fund to become fully committed within approximately three years and with investments in attractive projects with similar characteristics to our existing investments”.
Early this year, global investment firm BlackRock stated that concerns about the emerging climate crisis were beginning to flavour investment portfolios around the world. CEO Larry Fink told Bloomberg:
“Clients worldwide had been asking me repeatedly more and more about how should they frame a portfolio with climate change considerations. It was very clear to me that this is becoming a dominant theme in more and more of our investors”.
A number of similar projects have sprung up in recent months, with the UK’s own leading pension scheme Nest pledging to pump £5.5 billion into “climate aware” investments, and committed to decarbonising its entire portfolio by 2050.
Just two weeks ago, the European Commission announced its target to reduce its emissions by “at least” 55% by 2030 as the Union attempts to gain the title of the “first climate-neutral continent” in the world.
For more information, take a look at our guide to investing in 3 similar sustainable and climate-conscious funds, and why the threat of “greenwashing” poses a risk to distinguishing the sincerely good projects from the bad.
Asda has been sold by Walmart (NYSE: WMT) to two billionaire Blackburn-based brothers in a £6.8bn deal.
Mohsin and Zuber Issa are petrol station tycoons and backed by TDR Capital to buy the majority stake in the supermarket.
“We are very proud to be investing in Asda, an iconic British business that we have admired for many years,” said the Issa brothers in a statement.
“Asda’s customer-centric philosophy, focus on operational excellence and commitment to the communities in which it operates are the same values that we have built EG Group on,” they added.
The deal is expected to be completed early next year.
Chief executive Roger Burnley said on the deal: “This new ownership opens an exciting new chapter in Asda’s long heritage of delivering great value for UK shoppers.”
“With our combined investment, expertise and ambition; Asda, Walmart, the Issa brothers and TDR have an incredible opportunity to accelerate our existing strategy and develop an even more exciting offer for our customers as well as strengthen our business for our colleagues,” he added.
The Issa brothers have committed to £1bn investment over the next three years.
Walmart will continue an equity investment in the UK’s third-largest supermarket chain.
Judith McKenna, the chief executive officer of Walmart International, said: “I’m delighted that Walmart will retain a significant financial stake, a board seat and will continue as a strategic partner.”
Cenkos Securities shares (LON: CNKS) were trading +5.55% higher on Friday morning after the group shared interim results.
The securities group reported a pre-tax profit of £753,000 in the six months ending 30 June. This is compared to a £196,000 loss in the same period a year earlier.
Revenue at Cenkos Securities also surged by 21% to £12.9m.
The group has halved its interim dividend by 50% to 1p a share.
“The clear outcome of the 2019 general election made for an encouraging start to 2020 with an increase in asset values and the level of corporate activity. Since then the Coronavirus (“COVID‐19″) and the resulting lock down have had an unprecedented impact on economies around the world,” said chief executive, Jim Durkin in a statement.
“Our ongoing priority is the health and well‐being of our staff and I am grateful for the efforts of our IT team, who ensured an immediate and seamless switch to remote working and our HR and Facilities team for their work to make our office COVID‐secure, ready for our return.
“Swift action and our flexible operating model meant we have been fully operational throughout this time and therefore able to focus on our clients’ needs and assist them through this period. Indeed, the second quarter of 2020 saw a further increase in corporate activity, such that secondary funds raised on AIM were more than double that raised in the first quarter,” he added.
Cenkos Securities shares (LON: CNKS) are now trading +4.44% at 47.00 (1120GMT).
DeadHappy, a digital-first insurance provider, has surged past its £1.5M crowdfunding target on Seedrs and is now overfunding with more than £2.3M raised from over 850 investors.
As the company approaches their stretch target, the crowdfunding campaign will remain open for a limited time only, closing on 9 October 2020: Click here to invest!RIP long boring forms – hello DeadHappy
Recognised as one of the 15 exciting FinTech companies to watch in 2020, DeadHappy is on a mission to disrupt the £3.7bn life market by introducing a unique deathwish-based, pay-as-you-go life insurance product. Adopting a ‘digital-first’ approach, the company has taken a step away from the complex, expensive and boring world of traditional life insurance. Their streamlined online process – optimised for smart phones and tablets – allows customers to answer only four medical questions and obtain life insurance cover in under five minutes. The process is fast, transparent and hassle free.
Since launch, the company has insured over £1bn of cover and has had overwhelmingly positive customer feedback, with an NPS of 86 and a Trustpilot score of 4.9, from more than 500 reviews.
Life insurance to die for
Equipped with the idea of helping people think, talk and plan for what they want to happen when they die, DeadHappy offers a life insurance product based on deathwishes. Deathwishes help customers identify their life insurance needs and gives their life insurance plan some real, tangible meaning.
“Our Deathwish platform helps customers specify how they want their insurance payout to be used, such as pay off your mortgage or send your family on holiday,” says Phil Zeidler, Co-founder of DeadHappy. “Crucially, it acts as a catalyst to thinking about what you’d like to happen when you die and helps to open up those conversations with your loved ones.”
Launched in February 2019, the company’s ‘Deathwish Platform’ has seen over 120k deathwishes created to date.
The crowdfunding round
DeadHappy’s current crowdfund follows £5.5m investment to date from notable VCs Octopus and eVentures, both of whom are reinvesting in this round.
“As we look forward to the next stage of development for this company, we’re really excited to support them on their mission to change people’s attitudes to death,” said Malcom Ferguson, partner in Octopus Ventures.“And hopefully go some way to fixing the chronic underinsurance that exists in this sector.”
Why we invested in DeadHappy – Octopus Ventures from DeadHappy on Vimeo.
DeadHappy plans to use the funds raised to continue its rapid growth through marketing investment, launch new products, and accelerate the on-boarding of partners and sponsors.
The company’s round on Seedrs is set to close on the 9thof October 2020.
Click here to invest!
After being a private company for the past nine years, Playboy has revealed plans to list on the stock market.
In a deal that is valued at $415m (£323m), the company will merge with SPAC Mountain Crest Acquisition.
Playboy has transformed its business model and now describes itself as a consumer products company, selling clothing and gaming.
The merger is expected to be completed in 2021, when the group will be listed on the Nasdaq, the US stock market index.
Playboy chief executive Ben Kohn said: “The intention was always to return the company to public markets.”
“Our mission – to create a culture where all people can pursue pleasure – is rooted in our 67-year history and creates a clear focus for our business and role we play in people’s lives, providing them with the products, services and experiences that create a lifestyle of pleasure,” Kohn said in a statement.
“We are taking this step into the public markets because the committed capital will enable us to accelerate our product development and go-to-market strategies and to more rapidly build our direct-to-consumer capabilities,” he added.
On Friday’s opening, the FTSE 100 took a slide as markets prepare for the furlough scheme to end and the US President tested positive for coronavirus.
The FTSE 100 fell 0.7% to 5,837 points. European and Asian stocks also opened lower, whilst Wall Street is also expected to open lower amid the news of Donald Trump.
Trump tweeted on Friday: “Tonight, @FLOTUS and I tested positive for COVID-19. We will begin our quarantine and recovery process immediately. We will get through this TOGETHER!”
Fiona Cincotta, a market analyst from City Index, said: “The markets are already fretting about an uncertain election and this just adds another layer of uncertainty.”
Despite reassurances from Trump, many have noted that his age could lead to more severe forms of the disease. Polling day is in a month’s time on 3 November.
Shares on London’s blue-chip index are expected to come under pressure as the furlough scheme comes to an end and one in 10 employees in the UK are expected to lose their jobs.
“The Footsie remains fettered by investor insouciance and bleak prospects for the UK economy as a whole, down 23% in the year to date and seemingly unable to break out of its current narrow band,” said Richard Hunter, who is the head of markets at Interactive Investor.
“Further countries being added to the UK quarantine list alongside targeted local lockdowns have done little to lighten the mood, with the moves piling further pressure on several already beleaguered sectors.
“Large fundraisings announced by the likes of British Airways owner International Consolidated Airlines and Rolls-Royce are further indications of travel industry in turmoil,” he added.
Life insurance to die for
Equipped with the idea of helping people think, talk and plan for what they want to happen when they die, DeadHappy offers a life insurance product based on deathwishes. Deathwishes help customers identify their life insurance needs and gives their life insurance plan some real, tangible meaning.
“Our Deathwish platform helps customers specify how they want their insurance payout to be used, such as pay off your mortgage or send your family on holiday,” says Phil Zeidler, Co-founder of DeadHappy. “Crucially, it acts as a catalyst to thinking about what you’d like to happen when you die and helps to open up those conversations with your loved ones.”
Launched in February 2019, the company’s ‘Deathwish Platform’ has seen over 120k deathwishes created to date.
The crowdfunding round
DeadHappy’s current crowdfund follows £5.5m investment to date from notable VCs Octopus and eVentures, both of whom are reinvesting in this round.
“As we look forward to the next stage of development for this company, we’re really excited to support them on their mission to change people’s attitudes to death,” said Malcom Ferguson, partner in Octopus Ventures.“And hopefully go some way to fixing the chronic underinsurance that exists in this sector.”
Why we invested in DeadHappy – Octopus Ventures from DeadHappy on Vimeo.
DeadHappy plans to use the funds raised to continue its rapid growth through marketing investment, launch new products, and accelerate the on-boarding of partners and sponsors.
The company’s round on Seedrs is set to close on the 9thof October 2020.
Click here to invest!
